Analytics,dataAnalytics
Appearance,accuracy
Appearance,accuracyOfLesionDetection
Appearance,appearance
Appearance,case
Appearance,caseOf75-year-oldPatientWithDuctalInfiltratedCarcinoma
Appearance,caseReport
Appearance,change
Appearance,defectStudies
Appearance,importanceOfNondestructiveTestingInDefectStudies
Appearance,inNumericalSimulationsAccuratelyReconstructedWith90PercecntAccuracyUpToNoiseLevelOf50Percecnt
Appearance,orderOfAppearanceFrequency
Appearance,receiverOperatingCharacteristic
Applicability,applicability
Applicability,clinicalApplicability
Applicability,clinicalApplicabilityOfOurMethodInBreastCancerImagingSetting
Aptamer,aptamerMf3
Aptamer,ssdnaAptamerMf3
Areola,itSideEffects
Articles,Articles
Autoantibodies,autoantibodies
Autoantibodies,roleOfAutoantibodiesInEarlyCancerDiagnosis
Baseline,assessedAtBaseline
Baseline,patientsWithReducedBaselineLvef
Baseline,reducedBaselineCardiacFunction
Baseline,reducedBaselineLvef
Carcinoma,Carcinoma
Carcinoma,inflammatoryCarcinoma
Cavernous,cavernousMalformation
Cavernous,cavernousMalformationInduction
Cavernous,twoCasesOfCavernousMalformationFormationYears
Chemical,anastrozole
Chemical,baicalin
Chemical,bortezomib
Chemical,Cabergoline
Chemical,estrogen
Chemical,estrogens
Chemical,paclitaxel
Chemical,tamoxifen
Chemical,vitaminD
Collision,collisionTumorWithBreastCancerMetastasis
Collision,impact
Collision,impactOfStableKnockdownOfSmarcad1OnHumanBreastCancerCellProgression
Collision,recurrentWords
Collision,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Collision,typeOfCollisionTumor
Computer,Computer
Consensus,consensus
Consensus,consensusOnAssociationBetweenExposureToDdt
Covariance,covariance
Covariance,proposedCovariance
Craniotomy,craniotomy
Craniotomy,excision
Craniotomy,forPrecisionResectionUrgentInFieldOfDiagnosis
Craniotomy,incompleteExcisionOfMalignantTissues
Craniotomy,surgicalExcision
Craniotomy,surgicalExcisionWithRadiation
Cytology,aspirationCytology
Cytology,cytology
Cytology,fine-needleAspirationCytology
Cytology,intraoperativeScrapeCytology
Cytology,mitochondrialMorphology
Cytology,morphology
Cytology,surfaceMorphology
Disease,AD
Disease,advancedBreastCancer
Disease,amenorrhea
Disease,anxiety
Disease,autoimmuneDiseases
Disease,boneLoss
Disease,boneTumors
Disease,brainMetastasis
Disease,breastCancer
Disease,breastCancerStaging
Disease,cancer
Disease,cancerGenomeAtlas
Disease,cancer-relateddeaths
Disease,carcinoma
Disease,chorea
Disease,choreiformMovements
Disease,cleftLip/palate
Disease,CLP
Disease,collisionTumor
Disease,cowdenSyndrome
Disease,CS
Disease,cyanosis
Disease,death
Disease,ductalCarcinoma
Disease,elevatedLesion
Disease,erysipelatoidCarcinoma
Disease,erythema
Disease,FIT
Disease,GDM
Disease,heartFailure
Disease,her-2PositiveBreastCancer
Disease,hereditaryDiffuseGastricCancer
Disease,heterogeneousDisease
Disease,HT
Disease,Hyperprolactinemia
Disease,infertility
Disease,invasiveBreastCarcinoma
Disease,krukenbergTumors
Disease,localizedDisease
Disease,lungAdenocarcinomas
Disease,lungCancer
Disease,LVEF
Disease,lymphoma
Disease,macroprolactinomas
Disease,malformation
Disease,malignancy
Disease,malignantPleuralEffusion
Disease,metastases
Disease,metastaticDisease
Disease,micrometastasis
Disease,nausea
Disease,neoplasms
Disease,neuropathicPain
Disease,neuropathies
Disease,neuropathy
Disease,non-smallCellLungCancer
Disease,OS
Disease,overallSurvival
Disease,pain
Disease,paraneoplasticNeurologicSyndromes
Disease,pleuralMetastasis
Disease,primaryBreastDiffuseLargeB-cellLymphoma
Disease,Prolactinomas
Disease,RDD
Disease,superiorVenaCavaSyndrome
Disease,tataMemorialCancerHospital
Disease,triple-negativeBreastCancer
Disease,triple-negativeBreastCancers
Disease,tumor
Disease,tumors
Disease,UC
Disruption,disruption
Disruption,intrinsicDisruption
Disruption,postponementVisiting
Distance,boneDensity
Distance,breastImageneologicalSurveillanceBeginningAtAge
Distance,density
Distance,eConcentration
Distance,first
Distance,firstDataOnPre-diagnosisConcentrationsOfSrankl
Distance,firstDose
Distance,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Distance,firstSymptom
Distance,firstTime
Distance,firstTimeIn1984
Distance,firstYearsAfterWithdrawal
Distance,focalAsymmetricDensity
Distance,haveReportedForFirstTimeInCaninesInStudy
Distance,itsFirstDescription
Distance,shouldIdeallyAdministeredAtLeast1WeekBeforeCommencementOfAlkylatingTreatment
Distance,sinceItsFirstDescriptionAtInstituteOfPathologyInKielAgoHasShown
DNA,aberrantDnaMethylation
DNA,dnaMethylation
DNA,dnaMethylationDifferencesBetweenTumorBreastTissue
Document,associationBetweenNsaidsExposureInFemalePatientsWithAd
Document,balfContent
Document,balfContentOfProgranulinIn46NsclcPatientsBeforeChemotherapy
Document,content
Document,copyright
Document,ddtExposure
Document,document
Document,exponentialTiltingSemiparametricModelAccountForNonignorableMissingDataMechanism
Document,higherBalfContent
Document,improvedDiagnosticContentOverEx-vivoClinicalMammographyImagesAtLowerDose
Document,literature
Document,literatureForFamiliesWithCdh1Mutations
Document,model
Document,model2
Document,modelAccount
Document,nomogram
Document,nsaidExposure
Document,nsaidsExposure
Document,papers
Document,questionnaireBasedOnAnderson'SdelayModel
Document,threePapers
Drugs,chemotherapyDrugs
Drugs,conventionalChemotherapyDrugs
Drugs,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
Drugs,developmentOfNewDrugs
Dysplasia,binaryLogisticRegressionModels
Dysplasia,finalMultipleRegressionModel
Dysplasia,regressionModel
Dysplasia,regressionModels
Dysplasia,zero-inflatedPoissonRegression
Endocrine,adjuvantEndocrineHormonalTherapy
Endocrine,canEffectivelyTreatedByEndocrineTherapy
Endocrine,dealingWithEndocrineResistanceInPatientsWithBreastCancer
Endocrine,endocrineResistance
Endocrine,evidenceForEfficacyOfGonadotropin-releasingHormoneAgonists
Endocrine,hormoneReceptor-positiveTumors
Endocrine,imagingOfProstate
Endocrine,menopausalHormoneTherapy
Endocrine,patientsWithProstateCancer
Endocrine,pituitaryFunction
Endocrine,termsOfProlactinNormalizationInPituitaryFunction
Erythematous,boundErythematousAppearance
Erythematous,characterizedByAcuteAppearanceWithErythematousPlaqueSometimesHotMoreOftenSituatedInPrimaryTumorVicinity
Exposure,enlargement
Exposure,excellentPerformance
Exposure,finiteSamplePerformanceOfProposedMethods
Exposure,hemorrhagicEnlargement30YearsAfter
Exposure,performance
Exposure,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Extract,benefit
Extract,cause
Extract,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Extract,commonCause
Extract,commonCauseOfMorbidity
Extract,complementaryBenefit
Extract,mostCommonExtrinsicCause
Food,assay
Food,differencesInAssayPerformance
Food,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Food,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Food,goal
Food,heartFailureParticularly
Food,impairedBaselineCardiacFunctionExperience
Food,issue
Food,kernelApproach
Food,multiplexAssay
Food,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Food,patientEducationIdentification/reportingOfSideEffects
Food,symptomaticHeartFailure
Gene,CK5
Gene,Drp1
Gene,growthHormoneReceptor
Gene,HR
Gene,Mfn1
Gene,microRNA-22
Gene,MORC4
Gene,PAX8
Gene,Progranulin
Gene,RANKL
Gene,SMARCAD1
Gene,TTF-1
Gene,VDR
Gene,VEGF-D
Guidelines,guidelines
Guidelines,internationalGuidelines
HER-2,adultsWithHer-2PositiveBreastCancer
HER-2,caseOfWomanOnNeratinibForHer-2PositiveInfiltratingDuctalCarcinoma
Hyperglycemia,effect
Hyperglycemia,effectOfBaicalinInBreastCancer
Hyperglycemia,effectOfDdtSpraysOnBreastCancerIncidenceRate
Hyperglycemia,effectOnBoneRemodelingThroughItsReceptor
Hyperglycemia,highlyProblematicDose-limitingEffect
Images,featuresFromImages
Images,images
Images,increasedContrast-to-noiseRatioForMonochromaticOverClinicalImagesForWell-definedPhantom
Images,opticalCoherenceTomographyImages
Incorporation,associationsBetweenChangeOfPerceivedWorkAbility
Incorporation,chicagoStudy
Incorporation,descriptiveStudy
Incorporation,experimentalStudyOfCryo-stabilityOfCancerCells
Incorporation,includedInStudy
Incorporation,incorporation
Incorporation,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Incorporation,inPresentWorkHasProposedForBreastCancerDiagnosis
Incorporation,inStudyDevelopedByCell-selex
Incorporation,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Incorporation,ourStudy
Incorporation,perceivedWorkAbility
Incorporation,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Incorporation,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Incorporation,study
Incorporation,two-yearStudy
Incorporation,workAbility
Inhibition,Inhibition
Interference,chronicDebilitatingLifelongComplication
Interference,delivery
Interference,finalAssessment
Interference,intervention
Interference,interventionArm
Interference,scalableIntervention
Interference,shouldEstablishedBetweenScreeningWithImplementationOfRobustQualityAssurance
Interference,theory-basedIntervention
Interval,absence
Interval,chineseExpertGroup
Interval,controlGroup
Interval,correspondingHistologyImage
Interval,cycle
Interval,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Interval,fieldOfBreastCancerDetection
Interval,fieldOfMedicalImagesDiagnosis
Interval,g1/s-phaseCellCycleArrest
Interval,group
Interval,highestSeInTotalGroup
Interval,keyHypomethylationSites
Interval,keyRole
Interval,latencyPeriod
Interval,longPeriodOfTime
Interval,medianFollow-upPeriod
Interval,medianLatencyPeriod
Interval,note
Interval,period
Interval,periodFromApril2012ToDecember2017
Interval,postmenopausalPeriodWithDopamineAgonists
Interval,preliminaryGroupOfCtibl
Interval,state-of-the-artImageAnalysisMethods
Interval,totalGroup
Lifestyle,itsWater-bathSetup
Lifestyle,proposedTotal-variationSchemeWithSpatially-varyingAnisotropicWeightingCompensateForGeometricBiasFromLimitedAngleImagingSetup
Lifestyle,responseRate
Literacy,definitionOfHealthLiteracy
Literacy,influenceOfHealthLiteracyOnPathwayToCancerDiagnosis
Literacy,lowHealthLiteracy
Lymphedema,developmentOfLymphedema
Lymphedema,higherProportionOfPatientsWithLymphedema
Lymphedema,secondaryLymphedema
Lymphedema,unilateralBreastCancer-relatedLymphedema
Macroadenomas,macroadenomas
Macroadenomas,usuallyMacroadenomas
Malformation,malformationInduction
Markers,adequateSampleForAnalysisOfMolecularMarkersToGuidePatientsWithNon-smallCellLungCancerToAppropriateTargetedTherapies
Markers,diagnosticValueOfMarkers
Markers,immunohistochemicalMarkers
Markers,markers
Markers,markersOfMesothelioma
Markers,solubleMarkers
Mastectomies,bilateralMastectomies
Mastectomies,bilateralTotalMastectomies
Mastectomies,mastectomies
Membrane,antibodyPanel
Membrane,combinedPanel
Membrane,paraneoplasticAntibodyPanel
Microenvironment,fundamentalComponentsOfTumorMicroenvironment
Microenvironment,imbalanceInCytokineProfilesInPro-tumorigenicMicroenvironment
Microenvironment,pro-tumorigenicMicroenvironment
Mortality,mortalityRates
Mother,absorptionImagesAcquiredWithMonochromaticX-raysFromCompactSynchrotronSourceBasedOnInverseComptonScattering
Mutation,rs5743810
Neuropathy,chemotherapy-inducedNeuropathy
Neuropathy,commonPrimaryLesion
Neuropathy,irregularHyperintenseLesion
Neuropathy,irregularHyperintenseLesionInT2InLeftParietalRegion
Neuropathy,lesion
Neuropathy,poorAdhesion
Neuropathy,possibilityOfEarlyDetectionOfRiskOfOsteoporosisToItsDevelopment
Neuropathy,preventionOfChemotherapy-inducedNeuropathy
Neuropathy,relationToOccurrenceOfOsteoporosisAmongVariousEthnicGroups
Nondestructive,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Nondestructive,mostNondestructiveTests
Nondestructive,nondestructiveTesting
Nondestructive,nondestructiveTests
NSAID,nsaidUsers
NSAIDs,NSAIDs
Obstacle,adjustedHazardRatio
Obstacle,barrierFunction
Obstacle,collectionOfSignsResultingFromObstructionOfSuperiorVenaCavaIncludingSwellingOfUpperBodyOfHead
Obstacle,hazardRates
Obstacle,lowerCumulativeHazardRates
Oestrogen,oestrogenReceptorAlpha
Other,-916
Other,-1
Other,0.00001
Other,0.0001
Other,0.003
Other,0.02
Other,0.46
Other,1
Other,18.791
Other,19
Other,20
Other,77
Other,408
Other,1984
Other,Jan-90
Other,0-5Years
Other,1000Patients
Other,10Centers
Other,10-foldCross-validation
Other,10NeedContents
Other,10Percecnt
Other,120BreastCancerPatients
Other,120Patients
Other,12404Patients
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Other,13Percecnt
Other,13PercecntOfDeaths
Other,145Percecnt
Other,160Patients
Other,1722Comments
Other,192Months
Other,20PercecntForGata3
Other,20-year-oldWoman
Other,21Months
Other,23Patients
Other,2-3Years
Other,255Months
Other,25-year-oldWoman
Other,27-36MillionPatients
Other,2921Posts
Other,30Cm
Other,30DoublingTimesNecessary
Other,35-64Years
Other,3-timeAssessments
Other,44Percecnt
Other,46NsclcPatientsBeforeChemotherapy
Other,49Patients
Other,505Percecnt
Other,505PercecntOfAnalyzedCases
Other,510YearsAfterSurgery
Other,5-khzFrequencies
Other,6084Years
Other,62Years
Other,65Months
Other,65Ng/ml
Other,65Ng/mlForProgranulinFor-1
Other,65-year-oldFemale
Other,68Percecnt
Other,731Percecnt
Other,773Percecnt
Other,77Patients
Other,7Percecnt
Other,7PercecntForCdx2
Other,83Percecnt
Other,84Patients
Other,89Participants
Other,91Percecnt
Other,91PercecntInPatientsWithBreastTumors
Other,93Percecnt
Other,992Percecnt
Other,992PercecntOfCases
Other,99PercecntOfCases
Other,able
Other,acceptableSafetyMargins
Other,access
Other,accurateMethod
Other,acquisition
Other,actSynergisticallyWithPaclitaxel
Other,actualIncidence
Other,additionalInformation
Other,additionallyCorrelated
Other,add-onToConventionalUltrasoundEquipmentApplicable
Other,adherence
Other,adherenceToEhtAmongBreastCancerPatients
Other,adipocytes
Other,adjustedProportion
Other,adjuvantAnastrozole
Other,adPatients
Other,adulthood
Other,adultPatientsDiagnosed
Other,adults
Other,advancedAnalysis
Other,advancedComputationalSystems
Other,advancedStage
Other,advantage
Other,advantageOfHigh-throughputLuminexTechnique
Other,affected
Other,age-basedScreeningPrograms
Other,ages
Other,aim
Other,algorithm
Other,allBreastCancerPatients
Other,allow
Other,alsoAssociated
Other,alsoUsed
Other,alteredInHumanBreastCarcinoma
Other,alternative
Other,alternativeOption
Other,alternativeToFrozenSections
Other,amino-terminalFragment
Other,analysed
Other,analysis
Other,analysisInvestigate
Other,analyzed
Other,andfemales
Other,Angiogenesis
Other,annualMammographyAssociatedWithEchography
Other,anotherOfSeveralIndividualsInOneFamilyAffectedByCs
Other,anti-apoptoticEffectsOfEstradiol
Other,anticipatedOutcome
Other,anti-oncogenicRegulationOfMir-34s
Other,Applications
Other,applicationsOfRadiomics
Other,applied
Other,appliedTo70PatientsWithUnilateralRl
Other,approach
Other,appropriateAllocationOfResearchFunding
Other,appropriateIntegrationOfPreprocessing
Other,appropriateInterpretation
Other,appropriateQuality
Other,approximated
Other,approximately75PercecntOfBreastCancers
Other,area
Other,Areas
Other,arms
Other,article
Other,asianCountries
Other,asianPopulation
Other,aspect
Other,assessed
Other,assessments
Other,ASSIA
Other,associated
Other,associatedWithBreastCancerRisk
Other,associatedWithPfsAlthoughAtExtent
Other,association
Other,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
Other,associations
Other,associationsOfFactorsWithLocoregionalAtDiagnosis
Other,associationsWithDiseasesLikeTypeI
Other,associationWithImagingOfIgm
Other,asymptomaticWomen
Other,asymptoticPropertiesOfEstimatesCalculatedFrom
Other,attention
Other,attentionToSpecialGroups
Other,AUC
Other,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Other,automaticIntraoperativeIdentificationOfBreastCancerMargins
Other,autopsyStudies
Other,autosomal-dominantlyInheritedCancerSyndromeAssociatedWithRiskCausedByHeterozygousCdh1GermlineMutations
Other,available
Other,backgroundTrastuzumab
Other,balfOfNsclcPatients
Other,based
Other,Belgium
Other,bevacizumab-relatedCardiotoxicity
Other,bilateral
Other,bilateralInvolvement
Other,binding
Other,bindingSites
Other,bioimpedanceAnalysis
Other,bioinformaticAnalysis
Other,biologicalHeterogeneity
Other,biomarkers
Other,biopsy
Other,bLymphocyteChemoattractant
Other,body
Other,borders
Other,bortezomib-inducedColdAllodynia
Other,brain
Other,brainMetastases
Other,brainMetastasisFromPapillaryThyroidCarcinoma
Other,breast
Other,breastBiopsies
Other,breastCancerBrainMetastases
Other,breastCancerCare
Other,breastCancerCells
Other,breastCancerClassification
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
Other,breastCancerDetectionMethod
Other,breastCancerGrading
Other,breastCancerImagingSetting
Other,breastCancerIncidence
Other,breastCancerMcf-7
Other,breastCancerRisk
Other,breastCancerScreening
Other,breastCancerScreeningProgramme
Other,breastCancerStudies
Other,breastCancerTissue
Other,breastCancerTissues
Other,breastReconstruction
Other,breastScreening
Other,breastSurgery
Other,breastSurveillance
Other,breastTumorigenesis
Other,broadcasted
Other,broadUseToPatients
Other,burdenOfCervicalCancer
Other,byMultivariateAnalysisSignificantIndependentPrognosticFactorOfOs
Other,c.
Other,c1711
Other,ca15-3ByCmia
Other,cancerCare
Other,cancerCareNetwork
Other,cancerCells
Other,cancerManagement
Other,cancerPatients
Other,cancerProgression
Other,cancer-relatedDeathsAmongWomen
Other,cancerSurvivors
Other,canClassified
Other,canClassifiedAsSoluble-proteinBasedImmunocytochemical
Other,canDiagnosed
Other,canHeavilyInfluenced
Other,canIncluded
Other,canIncludedInDifferentialDiagnosisOfMasses
Other,canines
Other,canineTumours
Other,canOnlyDiagnosedOnPresentationOfSymptoms
Other,canStressful
Other,canStressfulToPatient
Other,capacities
Other,cardiotoxicRisk
Other,care
Other,careProvider
Other,Cases
Other,causes
Other,Cells
Other,centralRoleInBreastCancerResearch
Other,CESM
Other,CGI
Other,challenge
Other,challenges
Other,challenging
Other,challengingProblem
Other,changes
Other,characteristics
Other,characterized
Other,chemotherapy
Other,chemotherapyHormonalTreatment
Other,Chi
Other,China
Other,chinesePublic
Other,circulatingSolubleRankl
Other,CK
Other,ck5/6
Other,classificationOfMammograms
Other,clinicalBreastExamination
Other,clinicalBreastExaminationCoupledAsPrimaryTool
Other,clinicalCharacteristics
Other,clinicalDiagnosticPathways
Other,clinicalPractice
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Other,clinicalVisits
Other,clinico-epidemiologicalFeaturesOfBreastCancer
Other,closelyAssociated
Other,cm
Other,CMIA
Other,coding
Other,Co-existence
Other,collected
Other,collection
Other,combination
Other,combinedAnalysis
Other,common
Other,commonComplaint
Other,commonFinding
Other,commonMedications
Other,compactSynchrotronSources
Other,comparable
Other,compared
Other,comparingWithCurrentStandardMethodOfSubjectiveVisualEstimation
Other,comparison
Other,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,comparisonToCa15-3
Other,complaint
Other,complexSemisolidMasses
Other,complexSemisolidMassesWithVaryingAmountsOfSolidComponents
Other,components
Other,concentrations
Other,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Other,concerned
Other,concernForExistenceOfCancerCellsInGrafts
Other,conclusionsWomen
Other,concomitantlyShouldAnalyzed
Other,concurrentNeuroprotectiveDrugTherapy
Other,conducted
Other,conjugatedEquineEstrogen
Other,connection
Other,consequentlyPredicted
Other,considerableNumber
Other,consolidativeRadiotherapy
Other,consultations
Other,continuousDynamicCyclesOfFission
Other,continuousPattern
Other,continuousRisk
Other,contraceptiveUse
Other,contralateralBreast
Other,contrast-enhancedSpectralMammography
Other,contrastEnhancement
Other,contrastRatio
Other,contribution
Other,controlled
Other,controversial
Other,conventionalMagneticResonanceImaging
Other,convolutionalNeuralNetworks
Other,correctDiagnosis
Other,correlated
Other,correlativeEntities
Other,costData
Other,costs
Other,couldConsidered
Other,couldDetected
Other,couldDetectedEarly
Other,couldPotentialBiomarker
Other,couldSutegorized
Other,couldSutegorizedIntoT2aWithCutoffValueOf3Cm
Other,counseling
Other,countries
Other,coverageRates
Other,cpgIslands
Other,CRD42016048917
Other,created
Other,critical
Other,criticalImplicationsForTherapeuticDecision-makingInUrothelialCancer
Other,cross-sectionalCategories
Other,cross-sectionalStudies
Other,cross-validation
Other,crucial
Other,crucialRole
Other,Cryopreservation
Other,CTIBL
Other,cure
Other,currentlyUnclear
Other,currentTherapiesAvailable
Other,currentUtilizedHistopathologicBiomarkers
Other,cutoff
Other,cutoffValue
Other,cutoffValues
Other,cxcSubtypeOfChemokineSuperfamily
Other,cylindricalGeometries
Other,cystic
Other,Data
Other,dataOn108Pb-dllPatientsFrom21ChineseMedicalCenters
Other,datasets
Other,DAU
Other,dcisDiagnosis
Other,debated
Other,decision
Other,decreased
Other,decreasedGrowth
Other,decreasedRiskOfBreastCancerInFemaleAdPatients
Other,defined
Other,definition
Other,delay
Other,demonstrate
Other,denosumabInjection
Other,Depletion
Other,description
Other,descriptive
Other,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Other,designed
Other,detected
Other,detectedThroughScreeningThroughSigns
Other,detection
Other,detectionOfCancer
Other,determine
Other,determined
Other,devastatingDiagnosis
Other,developed
Other,development
Other,developmentOfBreastCancer
Other,developmentOfClinicalDecisionSupportSystemsForBreastCancerDiagnosis
Other,developmentOfGraphicallyTailoredScreeningTool
Other,developmentOfManyMetabolicDisorders
Other,developmentOfMetabolicDisorders
Other,diagnosis
Other,diagnosisInMajorityOfInconclusiveCases
Other,diagnosisOfBreastCancer
Other,diagnosisOfCancer
Other,diagnosisSystem
Other,diagnosticChallenge
Other,diagnosticPfBiomarkers
Other,diagnostics
Other,dictionaryLearning
Other,differences
Other,differentiallyExpressedInBreastCancerCells
Other,differentiallyModulated
Other,Differentiation
Other,differentmethodsOfSelf-treatment
Other,differentOss
Other,differentPhotosensitizerForPhotodynamicTherapy
Other,differentProtocols
Other,diffuse
Other,diffuseGastricCancerPresentedWithClp
Other,directlyAffectedByOverexpressionDownRegulationOfManyMirnas
Other,disadvantages
Other,disease
Other,diseaseDiagnosis
Other,diseases
Other,dissection
Other,dissectionOfLymphNodes
Other,distributions
Other,diverseBiologicalProcesses
Other,documented
Other,dominantArms
Other,dopamineAgonist
Other,dopamineAgonists
Other,dose
Other,doseConcerns
Other,double-maintenanceTherapy
Other,doublingTimeOfOccult
Other,downregulated
Other,downregulatedIn
Other,drawbacks
Other,drugBinding
Other,drugTherapy
Other,dual-energyAcquisition
Other,dual-luciferaseReporterAssays
Other,ductalCarcinoma
Other,earlierAges
Other,earlyBreastCancer
Other,earlyCancerDiagnosis
Other,earlyDiagnosis
Other,earlyStageDiagnosisOfTumors
Other,easternAsianMusculoskeletalOncologyGroup
Other,effective
Other,effects
Other,effectsOfTreatment
Other,efficacy
Other,efforts
Other,elevatedMitochondrialFission
Other,ELISA
Other,enforcedExpression
Other,enhancedPossibility
Other,enrolled
Other,environmentalFactors
Other,epidemiologicalFeatures
Other,eralphaSignalling
Other,eralphaTranscription
Other,ERN
Other,ernGenturis
Other,especiallyFrequentLateRelapsesInCnsBreast
Other,especiallyPost-neoadjuvantTreatment
Other,especiallyPromising
Other,essential
Other,estimated
Other,estimates
Other,estrogen-aloneArmOfWhi
Other,estrogenReceptor
Other,etiologyOfManyDiseases
Other,Europe
Other,europeanCountries
Other,evaluated
Other,evaluation
Other,evenAdjustedForKnownPrognosticFactors
Other,evenNeeded
Other,evenSubgroupOfPatientsTreatedWithRituximab
Other,evidence
Other,evidenceForbenefits
Other,exactTest
Other,examinations
Other,existence
Other,expected
Other,experts
Other,explored
Other,expressed
Other,expressedSeparately
Other,expression
Other,expressionInBreastCancer
Other,expressionLevels
Other,expressionOfOtherBiomarkers
Other,extendedAdjuvantTreatment
Other,extensiveAttentionOfResearchers
Other,extensiveExploration
Other,factor
Other,factors
Other,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Other,failure
Other,falsePositives
Other,familyMembers
Other,feasibilityStudies
Other,feature
Other,featureFactorsOfPrss
Other,featureMining
Other,featureMiningFromRois
Other,features
Other,female
Other,femaleBreastCancerMortality
Other,femalePatients
Other,femalePatientsWithAd
Other,fewLmics
Other,figures
Other,findings
Other,findingsFromStudies
Other,first-lineTreatment
Other,fission
Other,fiveMutationCarriers
Other,five-yearMetastasis-free
Other,five-yearOsRate
Other,flankingCgi
Other,focal
Other,focalNeurologicDeficit
Other,followed
Other,following
Other,forThoseWithNormalLvef93Percecnt
Other,forwardProblem
Other,found
Other,fpReduction
Other,fpReductionTechnique
Other,FPs
Other,frequent
Other,frequentInformationalNeeds
Other,frequentLateRelapses
Other,function
Other,functions
Other,fundamentalComponents
Other,furtherAdvancements
Other,furthermoreAssociated
Other,furtherResearch
Other,furtherStudies
Other,furtherUnderstanding
Other,fusionProteinsWithHaloTag
Other,future
Other,geneExpressionUpregulationInBreastCancer
Other,generalRadiologistAboutSystemicDiseases
Other,genes
Other,genesCodingForTumorSuppressorProteins
Other,geneticMalignancyPredispositionSyndrome
Other,geneticPredispositionForCancer
Other,geometries
Other,given
Other,glut1Expression
Other,grafts
Other,greaterthan1500Pg/ml
Other,greaterthanorequalto10PercecntReductionInLvef
Other,greaterthanorequaltoReduction
Other,greatestImportance
Other,greatPotentialInDiagnosisTherapyOfCancers
Other,greatProgress
Other,growing
Other,growingProblem
Other,growth
Other,growthImplicatedInTumorigenesis
Other,growthPotential
Other,GTPase
Other,gtpaseInBreastCancerCells
Other,guidePatients
Other,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Other,hasAchieved
Other,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Other,hasAssociated
Other,hasAssociatedWithPoorCancerScreeningUptake
Other,hasDescribedInFewHdgcFamilies
Other,hasDeveloped
Other,hasEstablished
Other,hasMade
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,has-miR-3158-3p
Other,hasProposed
Other,hasProven
Other,hasRecentlyDeveloped
Other,hasReduced
Other,hasReported
Other,hasUsed
Other,hasUsedInLeukemia
Other,hasValidatedDatabase
Other,haveAllProposedAmongPotentialPathways
Other,haveBackbone
Other,haveBackboneOfSuchEnormousStridesOfAu
Other,haveCenterstage
Other,haveProposed
Other,haveProven
Other,havePublished
Other,haveUsed
Other,haveYetProven
Other,hdgcTestingCriteria
Other,health
Other,healthcareCost
Other,healthCareSector
Other,healthcareUtilization
Other,healthInitiative
Other,healthySubjects
Other,hematoxylin
Other,her2Overexpressing
Other,her2-positiveA
Other,hereditaryBreast
Other,hereditaryCausesOfChorea
Other,heterogeneous
Other,hidden
Other,high
Other,highBurdenOfCancer
Other,highCorrelation
Other,higher
Other,higherProportion
Other,higherRatesOfMisdiagnosisForBreastCancer
Other,highestSe
Other,highGlut1Expression
Other,highlightConsiderations
Other,highlightImportantConsiderations
Other,highlyEffective
Other,highMortalityRateForFemales
Other,highPercentageOfRemissionMaintenance
Other,highVariability
Other,histopathologicalAnalysis
Other,histopathologicalDiagnostics
Other,histopathologicalreports
Other,historyPhysicalExamFindings
Other,hormone-dependentPositiveBreastCancer
Other,howeverKnown
Other,howeverLargelyUnreported
Other,howeverShouldPerformed
Other,howeverSwitched
Other,hugeImprovement
Other,hugeVolumes
Other,humanBody
Other,humanBreastNeoplasmsWithDeregulationOfSeveralMirnas
Other,humanLife
Other,humanPapillomavirusScreening
Other,hypomethylated
Other,hypomethylation
Other,hypomethylationSites
Other,hypothesis
Other,ICER
Other,ideallyPlaced
Other,identification
Other,identified
Other,idiopathicGranulomatousMastitis
Other,Images
Other,imaging
Other,imagingFeatures
Other,imbalance
Other,immediateReconstruction
Other,immediateUnmetNeed
Other,immediateUnmetNeedInClinicalPractice
Other,immune-mediatedCancer-associatedDisorders
Other,immunocytochemicalStudies
Other,immunohistochemicalAnalysis
Other,immunohistochemicalProliferationMarkerKi67
Other,immunohistochemicalTechniques
Other,implemented
Other,implications
Other,importance
Other,important
Other,importantAspect
Other,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Other,importantPhenotypicFeatureOfCdh1GermlineMutationCarriers
Other,importantPotential
Other,importantRole
Other,importantRoles
Other,improvedCancerTreatment
Other,improvedDiagnosis
Other,improvedDiagnostics
Other,improvement
Other,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Other,inCanadaOfferedInOrganizedPrograms
Other,inception-v3Cnn
Other,incidence
Other,included
Other,included.When
Other,inclusion
Other,inclusionCriteria
Other,inclusions
Other,inContextAppliedInClinicalDiagnosticsInClinicalTrialsForPurposeOfStratification
Other,incorrectDiagnosis
Other,increase
Other,increasedMalignantPotential
Other,increasedRisk
Other,increases
Other,incrementalCostOfCop$251049
Other,independentPrognosticFactor
Other,indicated
Other,indicationsForRisk-reducingSurgery
Other,indicative
Other,individuals
Other,inexpensive
Other,inexpensiveTechnique
Other,infiltrationSimilar
Other,inflammatory
Other,inflammatoryBreastDiseaseWithUnknownEtiology
Other,inflammatoryDiseases
Other,influences
Other,Information
Other,informationalNeedsByCancerType
Other,informationNeeds
Other,informationNeedsVary
Other,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,inherited
Other,inhibited
Other,inhibition
Other,inHumanBreastCancerHasReported
Other,initialTreatmentAfterWhich
Other,initiationOfBreastMalignancy
Other,initiationOfPromptTherapy
Other,inMarch2014BroadcastedAsPart
Other,inMultivariateModelsRelatedToPerformanceStatus
Other,innateImmuneSystems
Other,inOfGamma-ggtTransformedIntoNir-sn-nh
Other,inPreprocessingHasAchieved
Other,insight
Other,insights
Other,inspection
Other,intensive
Other,interactionEffects
Other,interplay
Other,interpretation
Other,interview
Other,invasive
Other,inverseLongitudinalAssociation
Other,inverseProblem
Other,investigate
Other,investigated
Other,invitedInputFromExpertsInSpecificAreas
Other,involved
Other,involvement
Other,involvementOfPtenInCs
Other,iraqiWomenWhencomparedToWesternWorld
Other,Irradiation
Other,isIdentified
Other,Israel
Other,It
Other,itEffects
Other,iterativelyModified
Other,its
Other,itsImportantRole
Other,itsImportantRoleInEtiologyOfManyDiseases
Other,itsReceptorLocatedInManyCellsOfBody
Other,itsRole
Other,itsUsefulness
Other,jak-statPathway
Other,Japan
Other,kaplanMeierCurves
Other,Ki67
Other,Kiel
Other,kind
Other,knowledge
Other,knowledgeGaps
Other,knowledgeOfM
Other,known
Other,knownHeterogeneousDisease
Other,Lack
Other,largelyUnknown
Other,largerStudies
Other,largestCancerInformationWebsite
Other,largestReviewOnPrsInAsianPopulation
Other,least
Other,leftParietalRegion
Other,less-effectiveChemotherapyAgents
Other,lessLikely
Other,levels
Other,levelsOfEralphaProtein
Other,life
Other,life-threatening
Other,likely
Other,likelyParaneoplastic
Other,limitations
Other,limited-angleFourier-domainSosReconstruction
Other,limitedHealthSystemCapacities
Other,linkage
Other,linked
Other,lisbonRegion
Other,Literature
Other,little
Other,LMICs
Other,lobularCarcinoma
Other,localEntropyMaximizationAlgorithm
Other,localizedDescription
Other,localizedDescriptionOfBreastCancer
Other,locoregionalDiseaseOfUnspecifiedLocation
Other,longerPfs
Other,longitudinalAssociation
Other,long-term
Other,long-termEstimates
Other,long-termUse
Other,loss
Other,lossOf020Quality-adjustedLifeYears
Other,lowCountries
Other,lowIncomeCountries
Other,lowRiskLesions
Other,lumbarSegments4-6
Other,lymphedemaseventyPatients
Other,M
Other,made
Other,magneticResonanceImaging
Other,main
Other,mainContribution
Other,mainlyEurope
Other,mammograms
Other,mammographicBreastCancerScreening
Other,mammography
Other,management
Other,manifold
Other,manyPatients
Other,manyWomen
Other,mapped
Other,mappedToPatientPathway
Other,markedlyUp-regulated
Other,mass/es
Other,masses
Other,mastectomizedWomen
Other,mastitis
Other,matthewsCorrelationCoefficientOf8038Percecnt
Other,mayImportantStepsDuringDiagnosis
Other,maySteps
Other,mean
Other,measurementSystem
Other,mechanism
Other,mechanisms
Other,medianProgression-freeSurvival
Other,medical
Other,medicalDiagnosisOfBreastCancer
Other,medicalHistory
Other,medicalKnowledge
Other,medications
Other,member
Other,members
Other,menopause
Other,metastasectomy
Other,metastasis-free
Other,metastaticBreastCancer
Other,metastaticDisease
Other,method
Other,methodologyOfInstitutoDeEvaluaciónTecnológicaEnSalud
Other,METHODS
Other,methylationStatus
Other,methylSpecific-multiplexLigationProbeAmplification
Other,microadenomasDataOnLong-termRemissionRate
Other,microRNA
Other,microrna-22ExpressionLevels
Other,microRNAs
Other,microscopicTesting
Other,mightUseful
Other,migration
Other,minimalRisksToNormalCells
Other,mir-193b-3pBinding
Other,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Other,mir-193b-3pIdentifiedAsRegulator
Other,miR-34s
Other,miRNA
Other,mirnaExpressionProfiles
Other,miRNAs
Other,mitochondrialFission
Other,mmp2Genes
Other,modificationPathways
Other,modified
Other,modulated
Other,molecularTesting
Other,morc4Silencing
Other,morcFamilyCw-typeZincFinger4Overexpression
Other,moreEasilyHypomethylated
Other,moreEffectiveTreatmentOfLungCancers
Other,moreoverAssociated
Other,moreoverMostOfTimeBenignRequired
Other,moreoverPoor
Other,moreoverStronglyRecommended
Other,moreRecommended
Other,mortality
Other,mortalityRate
Other,mortalityRates
Other,most
Other,mostCommonCancer
Other,mostCommonMalignantTumor
Other,mostCommonNeoplasms
Other,mostCommonUltrasonographicFindings
Other,mostEuropeanCountries
Other,mostFrequentMalignancy
Other,mostLikelyParaneoplastic
Other,mostlyBilateral
Other,mostOfPatientsDuringMammography
Other,mostPatients
Other,mostPervasiveTypeOfCancerAmongWomen
Other,mostPrevalentCancer
Other,mostRelevantKind
Other,mostTumors
Other,motivated
Other,mpMRI
Other,MRI
Other,mriImaging
Other,mrSystems
Other,mStage
Other,muchInterest
Other,multiparametricMri
Other,multipleBiologicalRolesIncludingParticipationInImmunosuppressiveStudies
Other,mutationCarriers
Other,mutations
Other,mutationsCarriers
Other,napsinAIn7Percecnt
Other,nature
Other,NCCN
Other,necessary
Other,need
Other,needed
Other,needs
Other,needsOfInformationSeekers
Other,negativeEffects
Other,negativeMargins
Other,networkOutput
Other,networks
Other,neurocognitiveSequelae
Other,neutralEffects
Other,newFpReductionTechnique
Other,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Other,news
Other,nf-krab-inducedIncreasedExpressionOfCcnd1
Other,node
Other,none
Other,Non-linearity
Other,normalCardiacFunction
Other,normalTissues
Other,novel
Other,novelInsightsIntoEpigeneticEvents
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Other,novelty
Other,nsclcPatientsAssociatedWithShorterOverallSurvival
Other,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Other,nuclearFactors
Other,number
Other,numberOfLong-termSurvivors
Other,numericalFull-waveSimulation
Other,objectives
Other,observed
Other,obtained
Other,obtainedFromMedicalSpecialists
Other,occultBreastTumors
Other,occurrenceOfBreastCarcinoma
Other,occurring
Other,occurringCancers
Other,offered
Other,oftenDebated
Other,oftenHypomethylated
Other,oftenRelated
Other,oncogenes
Other,oncogenesEsr1
Other,oncologicRisk
Other,oncology
Other,oncologyGroup
Other,oncoproteins/cancerSuppressors
Other,oneCancer
Other,oneFamilyAffectedByCs
Other,oneRegion
Other,oneRegionAnother
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Other,online
Other,only1ulOfSerumSample
Other,only20Percecnt
Other,onlyIndicative
Other,Ontario
Other,opportunities
Other,opportunitiesForResearchInBreastSurgery
Other,optimalCutoffValues
Other,osAdvantage
Other,osRate
Other,OSs
Other,otherData
Other,otherImagingCharacteristics
Other,others
Other,otherSubtypesOfBreastCancer
Other,ourData
Other,ourFindings
Other,ourMethod
Other,ourPatient
Other,ourProposedMethod
Other,ourTheoreticalAnalysis
Other,outcome
Other,output
Other,ovarianMetastases
Other,overallCumulativeRiskOfProgression
Other,overallMedianSurvival
Other,overexpressed
Other,Overexpression
Other,overview
Other,P
Other,painless
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
Other,pairedTumor
Other,paper
Other,paradigmaticExamples
Other,parameterUncertainty
Other,part
Other,particularEmphasisQuantifying
Other,particularlyPertinent
Other,pathogenesisOfBreastCancer
Other,pathologicalResults
Other,pathologicalSpecimen
Other,pathologistAnnotation
Other,pathways
Other,patientsByTrastuzumab-pretreatment
Other,patient'sMedicalHistory
Other,patients'MedicalRecords
Other,patients'Self-monitoring
Other,patientsWithBreastCancer
Other,patientsWithLocoregionalInSouthernPortuguese
Other,patientsWithMAmongThem
Other,pattern
Other,pax6GeneExpression
Other,pax6Inhibition
Other,pax6MethylationStatus
Other,pax6Overexpression
Other,pax6promoterMethylation
Other,pax8AMetastasesOfCancer
Other,PB-DLL
Other,PCI
Other,pdgfs/pdgfrsAxis
Other,percecnt
Other,percentage
Other,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,performed
Other,personalDecision-making
Other,pertinent
Other,PF
Other,pfBiomarkers
Other,PFS
Other,phosphatase
Other,place
Other,placed
Other,plasmaLevels
Other,polymorphism
Other,polymorphismOfFok1
Other,poor
Other,poorerPrognosisInPatients
Other,popular
Other,population-basedStudies
Other,populations
Other,portugueseWomen
Other,positive
Other,positiveFeedbackLoop
Other,positiveForGata3In93PercecntIn78PercecntOfCases
Other,possibility
Other,posteriorFossaOfBrain
Other,post-menopausalWomen
Other,potential
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,potentiallyCurativeRegimensOfCancerChemotherapy
Other,potentialSourcesOfVariance
Other,potentialTreatmentStrategy
Other,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Other,practitionerDecisionmaking
Other,pragmaticApproachToPopulation-basedCancerScreening
Other,precision
Other,predicted
Other,predominant
Other,predominantlyCystic
Other,presence
Other,presentation
Other,presented
Other,Prevalence
Other,prevention
Other,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Other,preventiveStrategies
Other,primaryCareProvider
Other,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,principles
Other,priorities
Other,Probes
Other,problem
Other,profiles
Other,prognosis
Other,prognosisMoreAccurately
Other,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Other,prognosticFactorsOfCancerProgression
Other,program
Other,programs
Other,progressionOfSeveralTypesOfNeoplasms
Other,prohibitivelyExpensive
Other,project
Other,projected
Other,proliferation
Other,promising
Other,promoterdnaMethylation
Other,properAccessToDiagnosis
Other,properFunctioningOfSkeletalSystem
Other,properties
Other,prophylacticBilateralSalpingo-oophorectomy
Other,prophylacticCranialIrradiation
Other,proportion
Other,proposed
Other,proposedForBreastTumorGrading
Other,proposedHowever
Other,proposedMethod
Other,proposedTechniqueResults
Other,protected
Other,protectiveRoleOfRs5743810
Other,proteinExpression
Other,proteinExpressionOfNf-krab-p65
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathway
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathwayInSpinalCordInLumbarSegments4-6
Other,proteinKinaseCInhibition
Other,proteinKinaseCInhibitors
Other,proteinS-100
Other,protocol
Other,protocols
Other,provedByExperimentalEvidence
Other,public
Other,publicHealthChallenge
Other,pulmonaryMetastases
Other,purpose
Other,QALY
Other,qualitativeApproach
Other,quality
Other,quantitative
Other,questionnaireAdministeredOnJapan'sLargestCancerInformationWebsite
Other,radiation
Other,radiomics
Other,radiotherapy
Other,randomisedTrials
Other,ranging
Other,rapidAdvancements
Other,rare
Other,rareCases
Other,rareSubtypeOfDllWithLimitedDataOnPatternsOfFailure
Other,rareTumor
Other,rate
Other,rates
Other,ratio
Other,realDataAnalysis
Other,realStatusOfPrs
Other,real-worldSetting
Other,receiving
Other,recentlyDevelopedBreastImagingTechnique
Other,recentlyHaveUsedAsBiomarkers
Other,recentYears
Other,receptorActivator
Other,recognizingMethylationStatus
Other,recommended
Other,recurrence
Other,recurrentHyperprolactinemia
Other,reductionOfFpsFrom085002Fp/imageForMias
Other,reference
Other,referenceForClinicians
Other,registered
Other,regressionAnalyses
Other,regulated
Other,regulationOfEnergyMetabolism
Other,regulationOfNras
Other,relapseRates
Other,related
Other,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Other,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Other,relevant
Other,remarkableImprovements
Other,remodeled
Other,report
Other,reported
Other,reporterAssays
Other,reports
Other,represented
Other,reproducingKernelHilbertSpace
Other,required
Other,research
Other,researchDevelopment
Other,Researchers
Other,resectedPrimaryLungCancer
Other,resonanceImaging
Other,respectivelyFound
Other,responsibleMechanisms
Other,restoration
Other,results
Other,resultsAberrantExpression
Other,resultsExpression
Other,Resurgery
Other,retrieved
Other,retrospective
Other,retrospectivelyReviewed
Other,reverseActiveLearningForClassificationOfHealthyBreastTissue
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Other,review
Other,reviewed
Other,right4
Other,rightMastectomyWithSentinelLymphNodeBiopsy
Other,risingTrendInMajorityOfLmics
Other,risingTrendOfColorectalCancers
Other,Risk
Other,riskForRecurrence
Other,riskOfBreastCancer
Other,riskOfBreastCancerInAdulthood
Other,riskOfDeath
Other,riskOfOtherLongTermAdverseHealthSequelae
Other,RiskProtection
Other,risk-reducingStrategies
Other,risks
Other,risksOfCancerInMutationsCarriers
Other,risk-stratifiedScreeningStrategy
Other,rituximab
Other,RL
Other,rnaKnockdown
Other,rnaOligonucleotides
Other,rnaSequenceAnalysis
Other,robustSynthesisMethods
Other,rocCurveAnalysis
Other,role
Other,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
Other,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
Other,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Other,roles
Other,roughly15000Cases
Other,roughly15000CasesPerYear
Other,rs5743810ProAllele
Other,RT
Other,ruralSetting
Other,salpingo-oophorectomy
Other,sample
Other,satisfied
Other,saudiArabianWomen
Other,scalable
Other,scarceReports
Other,scope
Other,screening
Other,screeningPrograms
Other,screeningStrategy
Other,SE
Other,search
Other,searched
Other,secondaryLymphoidTissueDevelopmentOfLymphocytesWithinMicrocompartmentsOfTissue
Other,secondaryLymphomatousInvolvement
Other,secondLargestHmo
Other,secondSurgery
Other,secondTumor
Other,secondValuedApproach
Other,secretion
Other,secretionOfTumorNecrosisFactor
Other,sectionLeads
Other,selected
Other,selectedPopulationsOfAfricanPatients
Other,selectPatientPopulations
Other,sentinelLymphNodeBiopsy
Other,sequelae
Other,serumCrust
Other,seValues
Other,sevenWomen
Other,severalIndividuals
Other,severalObjectives
Other,severe
Other,sexualityEvidence
Other,sexualityMoreEvidence
Other,shanxiProvinceOfChina
Other,shapes
Other,She
Other,shift
Other,shouldAdministered
Other,shouldAnalyzed
Other,shouldCo-managed
Other,shouldCo-managedByCardiologist
Other,shouldEstablished
Other,shouldPerformed
Other,shouldPerformedInAtRisk
Other,shouldProceede
Other,shouldProcessed
Other,shouldTested
Other,shown
Other,signalTransductionMoleculesIncludingProteinKinaseC
Other,significance
Other,significant
Other,significantAssociationBetweenRs5743810AllelicFrequency
Other,significantConnection
Other,significantEnrichmentOfCdh1MutationsWithinEcDomainsInComparisonToCdh1MutationsAssociatedWithHdgc
Other,significantIncrease
Other,significantlyDecreased
Other,significantlyReduced
Other,similar
Other,similarPfs
Other,simpleLow-costAlternative
Other,simulatedBreastCancer
Other,simulatedInnerBreastTissue
Other,simulation
Other,simulationStudies
Other,singleMetastaticSite
Other,sister
Other,sites
Other,size
Other,SNPs
Other,solubleMediators
Other,solved
Other,sosReconstruction
Other,sosValues
Other,southernPortuguese
Other,SP
Other,sparseCoding
Other,sparseCombinationOfRiemannianDictionaryAtoms
Other,specificAreas
Other,specificCircumstances
Other,specificityImprovement
Other,specimen
Other,Speed-of-sound
Other,SRS
Other,ssessed
Other,ssessedByWoundHealingAssayinAddition
Other,stableDrug-carrierBinding
Other,stageIi
Other,staining
Other,standard
Other,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Other,STAT1
Other,stat1RecruitmentToEralphaPromoterRegion
Other,state-of-the-artAlgorithms
Other,statisticallyCorrelated
Other,status
Other,Steps
Other,stillDifficult
Other,strategies
Other,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Other,strongLinkage
Other,studied
Other,Studies
Other,studiesFocused
Other,subgroupOfMacroprolactinomas
Other,substantialDelayFromDiagnosisToTreatment
Other,substantialRacial/ethnicDisparity
Other,successOfSymmetricPositiveDefiniteMatrices
Other,suchLowIncidence
Other,support
Other,supportVectorMachine
Other,suppressionOfBreastCancer
Other,surgeon
Other,surgery
Other,Survival
Other,survivalData
Other,survivalDifferences
Other,survivalOfCellsInVitroAndInVivo
Other,survivalRate
Other,survivalRatesOfLungCancerContinue
Other,suspected
Other,sutegories
Other,Sutegorization
Other,SVM
Other,SVM-BRC
Other,switched
Other,symptom
Other,symptomaticWomen
Other,Symptoms
Other,synchrotronSources
Other,syndrome
Other,syndromes
Other,synthesisMethods
Other,systemicChemotherapy
Other,systems
Other,T2
Other,t2bSutegory
Other,t2Category
Other,TAAs
Other,tackled
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Other,taken
Other,tanUsage
Other,target
Other,Targeting
Other,terms
Other,termsOfKyotoEncyclopediaOfGenes
Other,testing
Other,tests
Other,textureAnalysis
Other,thatOfOtherCountries
Other,theirContraceptivePreferences
Other,theirInteractions
Other,theirInteractionsLikeGene-gene
Other,theirOwnParticularity
Other,theirParticularity
Other,theirSelection
Other,them
Other,thenDefinedInReproductiveYears
Other,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,thenShouldTestedForSpecificGeneMutationFound
Other,thepresence
Other,therapeuticallyEffective
Other,therapeuticEffectsInBreastCancer
Other,therapies
Other,therapy
Other,thereforeCentralTarget
Other,thereforeRequired
Other,They
Other,third
Other,thirdInTermsOfSpecificMortality
Other,This
Other,three6-monthPeriods
Other,threeParadigmaticExamples
Other,thriceHigher
Other,thusCritical
Other,thusImportant
Other,thusPresented
Other,time
Other,timeOfTheirAppointmentwithDoctor
Other,tissueBiopsy
Other,tissueTumors
Other,tnmStaging
Other,tomography
Other,top10InformationalNeedContents
Other,total
Other,township
Other,transcoelomic
Other,transformed
Other,transitionProbabilities
Other,transport
Other,trastuzumab
Other,trastuzumab/pertuzumab/taxane
Other,trastuzumabInitiation
Other,trastuzumabTherapy
Other,trastuzumabTherapyForBreastCancer
Other,treated
Other,treatedWithIntraperitonealInjectionFor30Days
Other,treatment
Other,treatmentOfBreastCancer
Other,treatmentOfEuropeanPatients
Other,treatments
Other,treatmentWithWholeBrainRadiotherapy
Other,trend
Other,trials
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Other,tumorCells
Other,tumorEasily
Other,tumorGrowthInExperimentalModels
Other,tumorInformation
Other,tumorNecrosisFactor
Other,tumorSite
Other,tumorSites
Other,tumorSite-specificInformation
Other,tumorSuppressorFunction
Other,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Other,twoCases
Other,twoMoieties
Other,twoPathways
Other,twoSutegories
Other,two-thirdsOfBreastCancerCases
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Other,twoYears
Other,type
Other,type160Patients
Other,type1Diabetes
Other,typical
Other,typicalFeaturesIncludingFibrocysticBreastDisease
Other,typicalHormone-dependentTumor
Other,typicallyBilateral
Other,ultrasound
Other,unbiasedRnaSequenceAnalysis
Other,unclear
Other,uncommon
Other,undergoing
Other,underlyingCauses
Other,understanding
Other,understandingOfEmergingConceptsOfTumorBiology
Other,undifferentiatedNeoplasticCells
Other,uniqueProperties
Other,unknown
Other,unnecessarySubsequentExaminations
Other,un-recognized
Other,unreported
Other,unusual
Other,unusualImmuneProfiles
Other,unusualPresentationOfSuperiorVenaCavaSyndrome
Other,upregulated
Other,up-regulated
Other,uptake
Other,urgent
Other,urgentClinicalProblem
Other,us
Other,usd$901
Other,use
Other,used
Other,useful
Other,usefulness
Other,usualCare
Other,usuallyLong-term
Other,usuallyPerformed
Other,utility
Other,Utilization
Other,utilized
Other,Validation
Other,value
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,variousImportantFunctions
Other,variousOtherCancerInHumanBody
Other,variousStimuli
Other,varyingAmountsOfSolidComponents
Other,vdrExpression
Other,venaCavaSyndrome
Other,v-gCalciumChannelBindingAntibodies
Other,visits
Other,visualInspection
Other,visualizedTheranosticsOfTumors
Other,vitalRole
Other,vitalRoles
Other,volume
Other,volumes
Other,volumetricMeasurementSystem
Other,We
Other,westernBlotAnalysis
Other,whenPerformedBeforeMenopause
Other,whenSevere
Other,whenSuspected
Other,whereFacilitatedBySurfaceModificationOfNps
Other,whereFormulated
Other,WHI
Other,widelyKnown
Other,widelyUsed
Other,widelyUtilized
Other,willDifferent
Other,willDifferentRegardingSubtypeAtDiagnosis
Other,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Other,willTested
Other,willTestedThroughEuropeanMyPersonalBreastScreening
Other,willUsed
Other,willUsedAsReferences
Other,withFourier-domainReconstruction
Other,womenAcrossGlobe
Other,womenCarriers
Other,womenInWorld
Other,women'sCancerAccounting
Other,wordCloud
Other,world
Other,worldwideHighestAge-standardizedBreastCancerIncidence
Other,worseOsThanT2aSutegory
Other,xenograftMice
Other,years
Other,yetHasFirmlyEstablishedInClinicalPractice
Other,yetUnclear
Other,youngMexicanWomen
Plasticity,comparableToContrast-enhancedMriInTermsOfSensitivityAtFractionOfCost
Plasticity,mass
Plasticity,massInPosteriorFossaOfBrain
Plasticity,massMedia
Plasticity,one-waySensitivityAnalyses
Plasticity,sensitivity
Plasticity,sensitivityAnalysesresults
Plasticity,sensitivityOf786PercecntRespectively
Plasticity,univariateSensitivityAnalysesresults
Polymorphisms,occurrenceOfPolymorphisms
Polymorphisms,polymorphisms
Polymorphisms,polymorphismsImportant
Polymorphisms,resultsOfIndividualVdrPolymorphisms
Polymorphisms,vdrPolymorphisms
Probe,nirProbeNir-sn-ggt
Probe,probeNir-sn-ggt
Probe,remarkableEnzyme-activatedNirFluorescentProbeNir-sn-ggt
Provision,2-groupRandomizedControlTrial
Provision,60ControlPatients
Provision,activation
Provision,activationOfOther
Provision,breastCancerControlEfforts
Provision,breastCancerControlEffortsForIdentification
Provision,controlTrial
Provision,cytokineFunctionsLeadingToDevelopmentOfCancers
Provision,disturbance
Provision,follow-up
Provision,hasReducedThroughoutLastDecades
Provision,pathologyForFurtherFollow-up
Provision,provision
Provision,rangingFromDiagnosisPhaseToControlOfDisease
Provision,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
Quantification,observation
Quantification,whole-tumorSamplingOfDiseaseBurden
Regions,differentFunctionRegions
Regions,enhancerRegions
Relapse,betterResults
Relapse,betterUnderstanding
Relapse,betterUnderstandingOfRisksAssociatedWithM
Relapse,breastCancerRelapse
Relapse,continuousPatternOfRelapse
Relapse,greaterthanorequalto10PercecntDecline
Relapse,medianTimeToCnsRelapseOf31Years
Relapse,reductionOfRelapse
Relapse,relapse
Relapse,riskOfBreastRelapse
Relapse,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Resection,Resection
Resistance,action
Resistance,activity
Resistance,activityOfCellProliferationInBreastCancerCells
Resistance,application
Resistance,applicationOfPhase-sensitiveTechniques
Resistance,breastCancerCellInvasion
Resistance,breastCancerCellMigration
Resistance,capacity
Resistance,capacityForEarlyDiagnosisOfBreastCancer
Resistance,cell
Resistance,cellMigration
Resistance,characteristicsLikeCapacityForInvasion
Resistance,choiceOfImmunohistochemicalTechniques
Resistance,course
Resistance,lungCellCarcinomas
Resistance,moreImportantlyCanNowComplementedByEmergingDeepLearningTechniquesForFurtherProcessAutomation
Resistance,netvizzApplication
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Resistance,resistance
Resistance,suppressionOfCellSurvival
Resistance,tamoxifenResistance
Resistance,tediousCountingCell
Resistance,theirApplication
Resistance,vitaminDActivity
Sarcomas,forty-twoHigh-gradeSarcomas
Sarcomas,high-gradeSarcomas
Sarcomas,softTissueSarcomas
Scoring,nuclearAtypiaScoring
Scoring,Scoring
Similarities,similarities
Similarities,similaritiesInInformationalNeedsByCancerType
Similarities,similaritiesOfInformationRequired
Skin,alarmingLevelGlobally
Skin,aromataseInhibitor-inducedBoneLoss
Skin,balfLevel
Skin,bone
Skin,clinicalSecondLevelExamination
Skin,contextOfTwoCasesOfBladder
Skin,cut-offBalfLevel
Skin,geneExpressionLevel
Skin,level
Skin,levelExamination
Skin,needForAwarenessOfMimicsOfBoneMetastasis
Skin,pax6OverexpressionIncreasingMmp2Andmmp9ExpressionAtMrnaLevel
Skin,significanceLevel
Skin,twoCasesOfMimicsOfBoneMetastasis
Sleep,age
Sleep,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
Sleep,hadDiagnosedWithBreastCancerAtEarlyAge
Sleep,medianAge
Sleep,medianDiagnosisAge
Sleep,secondDecadeAfterDiagnosis
Sleep,threeYearsBeforeAge64Years
Species,Fisher
Species,mice
Species,participants
Species,patient
Species,patients
Species,woman
Species,women
Sprays,ddtSprays
Sprays,increaseWithNumberOfSprays
Surgeons,Surgeons
Users,12331Non-nsaidUsers
Users,12331Users
Users,non-nsaidUsers
Users,users